A Single Dose Study Of PF-06678552 In Healthy Subjects
NCT01992614
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
PF-06678552 or Placebo
DRUG:
PF-06678552 or Placebo
DRUG:
PF-06678552 or Placebo
Sponsor
Pfizer